Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Phobic Disorders: early-phase trial registry
1 of 6 indexed Phobic Disorders trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 1 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Phobic Disorders: 6 US clinical trials tracked, 1 recruiting.
Phobic Disorders is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is National Center for Complementary and Integrative Health (NCCIH), running 1 of these trials.
Enrollment posture brief
Registry condition phobic-disorders
OPEN 1 | RECR 17% | LATE 0 | EARLY 4 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)
Phobic Disorders lists 1 open slots (17% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Phobic Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Phobic Disorders is recruiting below its size-band peers.
1 of 6 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Phobic Disorders research.
National Center for Complementary and Integrative Health (NCCIH) accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Phobic Disorders enrolment sits around 124 participants.
Median target enrolment is 124 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.
-
Phobic Disorders research is mostly interventional.
6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Reward Processing and Exposure Therapy for Social Anxiety Disorder
University of California, Los Angeles
NCT06776991
A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder
Janssen Research & Development
NCT02432703
Treatment for Specific Phobias in Children
Virginia Polytechnic Institute and State University
NCT00051220
Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE)
Yale University
NCT02310152
Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia
National Institute of Mental Health (NIMH)
NCT00128401
St. John's Wort Versus Placebo in Social Phobia
National Center for Complementary and Integrative Health (NCCIH)
NCT00035412
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Phobic Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Phobic Disorders trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Phobic Disorders page
6 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Phobic Disorders trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Center for Complementary and Integrative Health (NCCIH) sponsors the most Phobic Disorders trials on record, review their full trial history before evaluating a specific study. See National Center for Complementary and Integrative Health (NCCIH)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Phobic Disorders condition card totals 6 registered trials; most-linked intervention Placebo; top US site state Connecticut. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.